<code id='526682DFD4'></code><style id='526682DFD4'></style>
    • <acronym id='526682DFD4'></acronym>
      <center id='526682DFD4'><center id='526682DFD4'><tfoot id='526682DFD4'></tfoot></center><abbr id='526682DFD4'><dir id='526682DFD4'><tfoot id='526682DFD4'></tfoot><noframes id='526682DFD4'>

    • <optgroup id='526682DFD4'><strike id='526682DFD4'><sup id='526682DFD4'></sup></strike><code id='526682DFD4'></code></optgroup>
        1. <b id='526682DFD4'><label id='526682DFD4'><select id='526682DFD4'><dt id='526682DFD4'><span id='526682DFD4'></span></dt></select></label></b><u id='526682DFD4'></u>
          <i id='526682DFD4'><strike id='526682DFD4'><tt id='526682DFD4'><pre id='526682DFD4'></pre></tt></strike></i>

          focus

          focus

          author:hotspot    Page View:8
          Stock photo of a surgeon holding a digital tablet in a medical setting – health tech coverage from STAT
          Adobe

          A new $50 million nonprofit initiative aims to independently evaluate health technologies’ impact on costs and quality, an attempt to help patients, payers, and providers sort over-hyped products from ones that actually move the needle.

          The Peterson Center on Healthcare, a nonprofit supporting programs that raise care quality and drive down costs, announced the new Peterson Health Technology Institute Tuesday. The institute plans to publish its methodology for assessing new health technology as soon as September, and start publishing reports on specific sectors, like disease types or tech mechanisms, in 2024, executive director Caroline Pearson told STAT.

          advertisement

          Especially after digital health investment surged early in the pandemic, health apps and software have proliferated — both those marketed to consumers and designed for organizations like health systems or insurers. Venture funding has since contracted, but customers are still faced with “an overwhelming number of solutions,” Pearson said. “It’s hard to know what is high value in this space.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Are embryos people? Reproductive medicine's future depends on the answer
          Are embryos people? Reproductive medicine's future depends on the answer

          AhumaneightcellembryoforIVFselection.K.HardyviaWellcomeCollectionTheannouncementthatSupremeCourtJust

          read more
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

          AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

          read more

          Pioneering cancer drug will cost $475,000. Analysts call it a bargain

          VictorSeguraIbarraandRitaSerda,Ph.D.,NCI,NIHTheFoodandDrugAdministrationonWednesdayapprovedafuturist